Aino Health AB (publ): Correction: Incorrect use of the MAR tag in previous press release “Aino Health AB (publ): Annual Report 2019”
2020-04-21
Aino Health AB (publ) sends out a correction for the press release “Aino Health AB (publ): Annual Report 2019”, which was published yesterday April 20, 2020 at 7.00 PM CEST.
The correction refers to that the press release was incorrectly tagged with the MAR tag referring to the EU Market Abuse Regulation. The MAR tag should not have been included.
For more information:
Jyrki Eklund, CEO Aino Health, Phone: +358 40 042 4221
Certified adviser
Erik Penser Bank
+46 8 463 83 00
certifiedadviser@penser.se
About Aino Health (publ)
Aino Health is the leading supplier of Software as a Service solutions in Corporate Health Management. The company’s complete system of SaaS platforms and services reduces sick leave, lowers related costs, and improves business results through increased productivity and employee engagement by making health, wellbeing, and safety an integrated part of everyday work. For more information visit ainohealth.com. Aino Health AB (publ) is listed on Nasdaq First North Growth Market (Ticker: AINO). For more information: ainohealth.com/
Upcoming Life Sciences Events
- April 2024
- London: LSX World Congress
- May 2024
- Seoul: BIO KOREA 2024
- Biotechgate Digital Partnering May 2024
Latest company news
There are currently no news available for this portal